Logiscreen

Co-Diagnostics Inc

$3.33
Market Cap 12.00M
ROE -164.9%
Gross Margin -32.8%
Debt/Equity 0.1
Current Ratio 2.3
Revenue QoQ 190.3%
EPS QoQ -0.4%
F-Score 1

About

Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to regulatory review and not currently for sale) and to identify genetic markers for use in applications other than infectious disease.

Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Devices

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-0.32
vs median 35.63
P/B
0.96
vs median 2.25
ROE
-1.65
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics